Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Moltó

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
The Lancet. Rheumatology|January 22, 2024
TNF inhibitor use during pregnancy in axial spondyloarthritis: are we asking the right questions?Anna Moltó
Arthritis Care & Research|September 8, 2018
ReplyAugustin Latourte, Anna Moltó
Frontiers in Medicine|March 30, 2018
Comorbidities in SpondyloarthritisAnna Moltó, Elena Nikiphorou
Best Practice & Research. Clinical Rheumatology|June 8, 2019
Comorbidities in spondyloarthritis including psoriatic arthritisAnna Moltó, Maxime Dougados
Annals of the Rheumatic Diseases|April 5, 2018
Response to: ' "Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study" by Moltó <i>et al</i>: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?' by Altobelli <i>et al</i>Anna Moltó, Maxime Dougados
Joint Bone Spine|January 5, 2010
Anti-IL-1 molecules: new comers and new indicationsAnna Moltó, Alejandro Olivé
Lancet (London, England)|June 11, 2019
Novel DMARD monotherapy in rheumatoid arthritisAnna Moltó, Maxime Dougados
Therapeutic Advances in Musculoskeletal Disease|November 2, 2020
Comorbid pain in axial spondyloarthritis, including fibromyalgiaClementina López-Medina, Anna Moltó
Best Practice & Research. Clinical Rheumatology|December 12, 2018
Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritisClementina López-Medina, Anna Moltó
Rheumatology International|November 25, 2021
Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology departmentElodie Portier, Maxime Dougados, Anna Moltó
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
The Lancet. Rheumatology|January 22, 2024
TNF inhibitor use during pregnancy in axial spondyloarthritis: are we asking the right questions?Anna Moltó
Arthritis Care & Research|September 8, 2018
ReplyAugustin Latourte, Anna Moltó
Frontiers in Medicine|March 30, 2018
Comorbidities in SpondyloarthritisAnna Moltó, Elena Nikiphorou
Best Practice & Research. Clinical Rheumatology|June 8, 2019
Comorbidities in spondyloarthritis including psoriatic arthritisAnna Moltó, Maxime Dougados
Annals of the Rheumatic Diseases|April 5, 2018
Response to: ' "Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study" by Moltó <i>et al</i>: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?' by Altobelli <i>et al</i>Anna Moltó, Maxime Dougados
Joint Bone Spine|January 5, 2010
Anti-IL-1 molecules: new comers and new indicationsAnna Moltó, Alejandro Olivé
Lancet (London, England)|June 11, 2019
Novel DMARD monotherapy in rheumatoid arthritisAnna Moltó, Maxime Dougados
Therapeutic Advances in Musculoskeletal Disease|November 2, 2020
Comorbid pain in axial spondyloarthritis, including fibromyalgiaClementina López-Medina, Anna Moltó
Best Practice & Research. Clinical Rheumatology|December 12, 2018
Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritisClementina López-Medina, Anna Moltó
Rheumatology International|November 25, 2021
Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology departmentElodie Portier, Maxime Dougados, Anna Moltó
Pageof 8